COMP <GO>
NYT vs PG // PIOTROSKI F-SCORE QUALITY
New York Times Company (The) (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: NYT 5
— PG 10
▲ PIOTROSKI F-SCORE QUALITY LEADER: NYT
LAST: $70.17 (+1.08%) • MKT CAP: $11.14B
piotroski-score
9/9
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NYT VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NYT | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 51.20% | -10.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.30% | 25.40% | -11.10 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.0x | 16.2x | +8.80 | PG | /valuation <GO> |
| Free Cash Flow Yield | 4.94% | 3.77% | +1.17 | NYT | /fcf-yield <GO> |
| Operating Margin | 15.30% | 24.30% | -9.00 | PG | /operating-margins <GO> |
| Net Profit Margin | 12.20% | 19.00% | -6.80 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 9.20% | 0.30% | +8.90 | NYT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.99% | 2.65% | -1.66 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.40 | 5.59 | +1.81 | NYT | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 9/9 | 7/9 | +2.00 | NYT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.50% | +0.40 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.7 | 62.7 | -2.95 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.87 | +0.14 | NYT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.1x | 21.7x | +8.40 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.14B | $372.21B | -$361.07B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NYT REV | PG REV | NYT GROSS % | PG GROSS % | NYT FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.82B | $84.28B | 44.0% | 51.2% | $550.5M | $14.04B |
| FY 2024 | $2.59B | $84.04B | 44.0% | 51.4% | $381.3M | $16.52B |
| FY 2023 | $2.43B | $82.01B | 44.0% | 44.0% | $251.4M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NYT // BETA 1.01
PG // BETA 0.87